NCTR – July 27th, 2010
The latest issue of the New Companies & Technologies Report (NCTR) has been published on innovative companies and technologies in health and medicine. * If […]
Month: July 2010
New Imaging Technique May Provide a Closer Look at Cell Death
The information could allow researchers to observe cellular changes as a patient undergoes cancer treatment, and could aid in the development of new molecular therapeutics for diseases such as cancer.
Nektar Announces Positive Data on Ovarian Cancer Drug
An experimental drug from Nektar Therapeutics was able to shrink tumors and reduce a cancer biomarker in women with advanced ovarian cancer in a mid-stage study.
Celiac Disease: A Significant, Unmet Clinical Need
A disease that affects a significant number of Americans, that requires extensive and often frustrating lifestyle modifications, and that has no approved pharmaceutical treatment: It’s an enticing opportunity for drug companies.
Cholesterol Drugs May Slow Diabetic Vision Loss, Study Finds
A large-scale study funded by the National Institutes of Health found that both blood sugar control and a combination of cholesterol-lowering lipid drugs were effective in slowing the progression of diabetic retinopathy.
Here Come the Robots
Surgical robots were once considered a fantastical invention of sci-fi authors. But the future, as they say, is now.
DataPhysics Research Rides to the Rescue of Radiologists
The technology company has developed CaseReader, a turnkey software solution designed to help radiologists conduct faster, more accurate analyses.
Healthcare IT Innovations Featured at OneMedForum
Healthcare IT has the potential to improve operational efficiency and lower medical costs—huge potential benefits in the era of healthcare reform.
Michael Bloomberg Proclaims “OneMedForum Days” in New York City
The OneMedForum was recognized by Michael R. Bloomberg, Mayor of New York City, as an important event supporting innovation in the healthcare and life science industries.
NeuroPace Files with FDA for Epilepsy Device
NeuroPace, a company focused on implantable devices for the treatment of brain disorders, announced Thursday that it has filed for Pre-Market Approval with the U.S. Food and Drug Administration for its investigational device for epilepsy patients.